# Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients

> **NCT00895583** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 254 (actual)

## Conditions studied

- Graft Rejection
- Kidney Transplant
- Renal Allograft Recipients
- Renal Transplant

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Sirolimus
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT00895583
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 254 (ACTUAL)
- **Last updated:** 2014-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00895583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00895583, "Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00895583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*